flu season to boost jb pharma's volumes? | nikhil chopra explains | business news | et now
Published 1 year ago • 579 plays • Length 7:50Download video MP4
Download video MP3
Similar videos
-
14:13
guidance for ebitda margin is 24-26% in fy23 | nikhil chopra, jb chemicals | top market news |et now
-
6:42
looking at newer forms of delivery of drugs in cdmo business | nikhil chopra explains | et now
-
5:51
jb pharma q3: new launches aid growth | nikhil chopra | earnings with et now
-
11:20
q3 performance and growth outlook | nikhil chopra, jb chemicals
-
8:09
volume growth is at 8-10%: jb pharma | cnbc tv18
-
3:24
the new generation at jb chemicals
-
4:37
we skipped flu season. that's bad
-
1:21:39
jb chemicals and pharma earnings call for q4fy22
-
9:31
jb chemicals' nikhil chopra speaks on the firm's fy23 outlook | halftime report | cnbc-tv18
-
8:15
jb chemicals & pharmaceuticals' nikhil chopra on q4fy23 earnings | halftime report | cnbctv18
-
9:42
jb chemicals wants to be in the top 10 when it comes to being a prescription co | cnbc tv18
-
1:30
jb pharma strengthens its position in gastroenterology with launch of ranraft
-
2:50
flu season nears peak later than usual
-
4:00
why is the flu so bad this year? | cnbc
-
0:30
flu season on track to break records
-
1:31
jb pharma acquires razel franchise from glenmark for ₹314 crore | halftime report | cnbc-tv18
-
2:19
the latest uptick in this year's flu season
-
1:40
upcoming flu season expected to be a tough one
-
3:07
flu season is almost here: everything you need to know
-
4:08
news par views : anil singhvi in talk with nikhil chopra, ceo & wtd, j.b. chemicals & pharma.
-
2:10
this season's flu vaccine is only 23% effective